Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers [proceedings].
作者信息
Bennett A, Berstock D A, Raja B, Stamford I F
出版信息
Br J Pharmacol. 1979 Jul;66(3):451P.
Abstract
摘要
相似文献
1
2
Human cancer prostaglandins and patient survival.人类癌症中的前列腺素与患者生存率。
Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:875-8.
3
[Surgery of breast cancer and date of last menstruation].[乳腺癌手术与末次月经日期]
Bull Cancer. 1993 Feb;80(2):111-2.
4
Prostaglandin production and metabolism in human breast cancer.人类乳腺癌中前列腺素的产生与代谢
Adv Prostaglandin Thromboxane Res. 1980;6:575-80.
5
[Statistical notes on the age and survival of 178 patients operated for malignant breast tumors].[178例接受恶性乳腺肿瘤手术患者的年龄及生存情况统计说明]
Minerva Chir. 1975 Nov 30;30(22):1140-4.
6
Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases.早期乳腺癌保乳治疗后局部复发，约57例。
Cancer Radiother. 2004 Apr;8(2):95-107. doi: 10.1016/j.canrad.2004.01.002.
7
[The surgery of breast carcinoma. 10 years of activity].
Minerva Chir. 1997 May;52(5):531-48.
8
Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.确诊手术后发生远处转移的乳腺癌患者生存的预后因素。
Singapore Med J. 2008 Nov;49(11):904-11.
9
Factors predicting in-breast tumor recurrence after breast-conserving surgery.保乳手术后乳腺肿瘤复发的预测因素。
Breast Cancer Res Treat. 2009 Jul;116(1):171-7. doi: 10.1007/s10549-008-0187-y. Epub 2008 Sep 25.
10
The role of surgery in breast cancer patients with isolated bone metastases at the time of diagnosis.手术在诊断时伴有孤立性骨转移的乳腺癌患者中的作用。
J Surg Oncol. 2009 Aug 1;100(2):95-9. doi: 10.1002/jso.21300.
引用本文的文献
1
Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.舒林酸，一种非甾体抗炎药，作为一种免疫调节剂介导乳腺癌抑制作用。
Sci Rep. 2016 Jan 18;6:19534. doi: 10.1038/srep19534.
2
COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients.COX2在高级别乳腺癌中的表达：三阴性乳腺癌患者亚组中预后意义的证据。
Med Oncol. 2014 Jun;31(6):989. doi: 10.1007/s12032-014-0989-1. Epub 2014 May 10.
3
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?环氧化酶-2及其在癌症中的抑制作用：有作用吗？
Drugs. 2007;67(6):821-45. doi: 10.2165/00003495-200767060-00001.
4
Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.非内分泌和内分泌肿瘤中的环氧化酶-2与血栓素合酶：综述
Endocr Pathol. 2005 Winter;16(4):253-77. doi: 10.1385/ep:16:4:253.
5
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.环氧化酶抑制剂可调节控制转移性疾病的自然杀伤细胞活性。
Cancer Immunol Immunother. 2005 Oct;54(10):981-7. doi: 10.1007/s00262-005-0669-2. Epub 2005 May 13.
6
Promoter methylation regulates cyclooxygenase expression in breast cancer.启动子甲基化调控乳腺癌中环氧合酶的表达。
Breast Cancer Res. 2004;6(4):R316-21. doi: 10.1186/bcr793. Epub 2004 Apr 26.
7
Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.源自乳腺癌的前列腺素E2对白介素-12基因表达的调控及其抗肿瘤活性
J Leukoc Biol. 2004 Aug;76(2):322-32. doi: 10.1189/jlb.1203641. Epub 2004 May 3.
8
Prostaglandin-like material extracted from squamous carcinomas of the head and neck.从头部和颈部鳞状癌中提取的类前列腺素物质。
Br J Cancer. 1980 Feb;41(2):204-8. doi: 10.1038/bjc.1980.31.
9
Endogenous prostaglandin production by established cultures of neoplastic rat mammary epithelial cells.已建立的大鼠乳腺肿瘤上皮细胞培养物产生内源性前列腺素的情况。
In Vitro. 1984 Feb;20(2):119-26. doi: 10.1007/BF02626652.
10
Prostaglandins in breast cancer: relationship to disease stage and hormone status.乳腺癌中的前列腺素：与疾病分期及激素状态的关系。
Br J Cancer. 1983 Nov;48(5):689-96. doi: 10.1038/bjc.1983.251.
本文引用的文献
1
Prostaglandins and breast cancer.前列腺素与乳腺癌
Lancet. 1977 Sep 24;2(8039):624-6. doi: 10.1016/s0140-6736(77)92496-5.
Zotero 插件